Literature DB >> 19116259

Mobilization of endogenous retroviruses in mice after infection with an exogenous retrovirus.

Leonard H Evans1, A S M Alamgir, Nick Owens, Nick Weber, Kimmo Virtaneva, Kent Barbian, Amenah Babar, Frank Malik, Kyle Rosenke.   

Abstract

Mammalian genomes harbor a large number of retroviral elements acquired as germ line insertions during evolution. Although many of the endogenous retroviruses are defective, several contain one or more intact viral genes that are expressed under certain physiological or pathological conditions. This is true of the endogenous polytropic retroviruses that generate recombinant polytropic murine leukemia viruses (MuLVs). In these recombinants the env gene sequences of exogenous ecotropic MuLVs are replaced with env gene sequences from an endogenous polytropic retrovirus. Although replication-competent endogenous polytropic retroviruses have not been observed, the recombinant polytropic viruses are capable of replicating in numerous species. Recombination occurs during reverse transcription of a virion RNA heterodimer comprised of an RNA transcript from an endogenous polytropic virus and an RNA transcript from an exogenous ecotropic MuLV RNA. It is possible that homodimers corresponding to two full-length endogenous RNA genomes are also packaged. Thus, infection by an exogenous virus may result not only in recombination with endogenous sequences, but also in the mobilization of complete endogenous retrovirus genomes via pseudotyping within exogenous retroviral virions. We report that the infection of mice with an ecotropic virus results in pseudotyping of intact endogenous viruses that have not undergone recombination. The endogenous retroviruses infect and are integrated into target cell genomes and subsequently replicate and spread as pseudotyped viruses. The mobilization of endogenous retroviruses upon infection with an exogenous retrovirus may represent a major interaction of exogenous retroviruses with endogenous retroviruses and may have profound effects on the pathogenicity of retroviral infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116259      PMCID: PMC2648265          DOI: 10.1128/JVI.01926-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Homologous recombination of copackaged retrovirus RNAs during reverse transcription.

Authors:  H Stuhlmann; P Berg
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 2.  Genetic control of retrovirus susceptibility in mammalian cells.

Authors:  Stephen P Goff
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

3.  Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination.

Authors:  W S Hu; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  The four classes of endogenous murine leukemia virus: structural relationships and potential for recombination.

Authors:  J P Stoye; J M Coffin
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

5.  Expression analyses of human endogenous retroviruses (HERVs): tissue-specific and developmental stage-dependent expression of HERVs.

Authors:  Goichi Okahara; Shinobu Matsubara; Takaya Oda; Jun Sugimoto; Yoshihiro Jinno; Fuminori Kanaya
Journal:  Genomics       Date:  2004-12       Impact factor: 5.736

6.  Genetic analysis of Gv1, a gene controlling transcription of endogenous murine polytropic proviruses.

Authors:  P L Oliver; J P Stoye
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference.

Authors:  M Lavignon; L Evans
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Dissection of genetic mechanisms governing the expression of serum retroviral gp70 implicated in murine lupus nephritis.

Authors:  Lucie Baudino; Kumiko Yoshinobu; Naoki Morito; Shuichi Kikuchi; Liliane Fossati-Jimack; Bernard J Morley; Timothy J Vyse; Sachiko Hirose; Trine N Jørgensen; Rebecca M Tucker; Christina L Roark; Brian L Kotzin; Leonard H Evans; Shozo Izui
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

9.  A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ectropic, amphotropic, xenotropic, and mink cell focus-forming viruses.

Authors:  M R Lander; S K Chattopadhyay
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

10.  Endogenous nonecotropic proviruses mapped with oligonucleotide probes from the long terminal repeat region.

Authors:  W N Frankel; J M Coffin
Journal:  Mamm Genome       Date:  1994-05       Impact factor: 2.957

View more
  27 in total

1.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  A novel active endogenous retrovirus family contributes to genome variability in rat inbred strains.

Authors:  Yongming Wang; Frantisek Liska; Claudia Gosele; Lucie Sedová; Vladimír Kren; Drahomíra Krenová; Zoltán Ivics; Norbert Hubner; Zsuzsanna Izsvák
Journal:  Genome Res       Date:  2009-11-03       Impact factor: 9.043

Review 3.  Pragmatic turn in biology: From biological molecules to genetic content operators.

Authors:  Guenther Witzany
Journal:  World J Biol Chem       Date:  2014-08-26

4.  Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences.

Authors:  Rafael Contreras-Galindo; Mark H Kaplan; Derek Dube; Marta J Gonzalez-Hernandez; Susana Chan; Fan Meng; Manhong Dai; Gilbert S Omenn; Scott D Gitlin; David M Markovitz
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 5.  Transmission, Evolution, and Endogenization: Lessons Learned from Recent Retroviral Invasions.

Authors:  Alex D Greenwood; Yasuko Ishida; Sean P O'Brien; Alfred L Roca; Maribeth V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2017-12-13       Impact factor: 11.056

6.  HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.

Authors:  R Brad Jones; Keith E Garrison; Shariq Mujib; Vesna Mihajlovic; Nasra Aidarus; Diana V Hunter; Eric Martin; Vivek M John; Wei Zhan; Nabil F Faruk; Gabor Gyenes; Neil C Sheppard; Ingrid M Priumboom-Brees; David A Goodwin; Lianchun Chen; Melanie Rieger; Sophie Muscat-King; Peter T Loudon; Cole Stanley; Sara J Holditch; Jessica C Wong; Kiera Clayton; Erick Duan; Haihan Song; Yang Xu; Devi SenGupta; Ravi Tandon; Jonah B Sacha; Mark A Brockman; Erika Benko; Colin Kovacs; Douglas F Nixon; Mario A Ostrowski
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

7.  Endogenous gammaretrovirus acquisition in Mus musculus subspecies carrying functional variants of the XPR1 virus receptor.

Authors:  Devinka Bamunusinghe; Qingping Liu; Xiaoyu Lu; Andrew Oler; Christine A Kozak
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

8.  Recombinant Origins of Pathogenic and Nonpathogenic Mouse Gammaretroviruses with Polytropic Host Range.

Authors:  Devinka Bamunusinghe; Qingping Liu; Ronald Plishka; Michael A Dolan; Matthew Skorski; Andrew J Oler; Venkat R K Yedavalli; Alicia Buckler-White; Janet W Hartley; Christine A Kozak
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

9.  Endogenous retroviruses mobilized during friend murine leukemia virus infection.

Authors:  Stefano Boi; Kyle Rosenke; Ethan Hansen; Duncan Hendrick; Frank Malik; Leonard H Evans
Journal:  Virology       Date:  2016-09-19       Impact factor: 3.616

10.  Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.

Authors:  Marta J Gonzalez-Hernandez; James D Cavalcoli; Maureen A Sartor; Rafael Contreras-Galindo; Fan Meng; Manhong Dai; Derek Dube; Anjan K Saha; Scott D Gitlin; Gilbert S Omenn; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.